The Harvard spinout has raised a second funding round that included existing shareholder Cedars-Sinai, boosting its total equity funding to $40m.

Emulate, a US-based biotechnology spinout of Harvard University’s Wyss Institute, raised $28m in a series B round backed by hospital Cedars-Sinai Medical Center on Monday.

NanoDimension, OS Fund, Atel Ventures, Leandro P Rizzuto Foundation’s ALS Finding a Cure program, private investor Hansjörg Wyss and an additional, unnamed investor also participated in the round.

Founded in 2013, Emulate is developing organs-on-chips technology. The chips are the size of small batteries and contain tens of thousands of living human cells…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?